Sign Up Today and Learn More About Strand Therapeutics Stock
Invest in or calculate the value of your shares in Strand Therapeutics or other pre-IPO companies through EquityZen's platform.
Strand Therapeutics Stock (STRT)
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
About Strand Therapeutics Stock
Founded
2017
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Strand Therapeutics Press Mentions
Stay in the know about the latest news on Strand Therapeutics
Ryan Sowell on LinkedIn: Strand Therapeutics Announces First Patient Dosed with Programmable mRNA…
linkedin • Aug 03, 2024
Samta Kundu on LinkedIn: Strand Therapeutics Announces First Patient Dosed with Programmable mRNA…
linkedin • Jun 25, 2024
Strand Therapeutics Announces First Patient Dosed with Programmable mRNA Therapy STX-001 in Phase 1 Trial for ...
businesswire • Jun 25, 2024
Seven groundbreaking mRNA companies to look out for
labiotech • May 20, 2024
Expression constructs and uses of these
patents • Apr 15, 2024
Strand Therapeutics Management
Leadership team at Strand Therapeutics
Co-Founder, SAB member
Darrell Irvine
Chief Business Officer
Jay Stella
Join now and verify your accreditation status to gain access to:
- Strand Therapeutics current valuation
- Strand Therapeutics stock price
- Available deals in Strand Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Strand Therapeutics Stock
How to invest in Strand Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Strand Therapeutics through EquityZen funds. These investments are made available by existing Strand Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Strand Therapeutics stock?
Shareholders can sell their Strand Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
